as of 11-28-2025 9:31am EST
Sera Prognostics Inc is a health diagnostic company. It develops diagnostic tests for the early prediction of a woman's individualized risk of premature birth, preeclampsia, gestational diabetes, stillbirth, and other conditions. The proprietary proteomics and bioinformatics platform of the company helps to improve maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services. The Company operates as one operating segment, which is developing and commercializing its medical diagnostic products and services.
| Founded: | 2008 | Country: | United States |
| Employees: | N/A | City: | SALT LAKE CITY |
| Market Cap: | 90.6M | IPO Year: | 2021 |
| Target Price: | N/A | AVG Volume (30 days): | 34.9K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.75 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.37 - $9.13 | Next Earning Date: | 11-13-2025 |
| Revenue: | $95,000 | Revenue Growth: | 1.06% |
| Revenue Growth (this year): | 217.92% | Revenue Growth (next year): | 479.25% |
Machine learning model trained on 25+ technical indicators
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Chief Scientific Officer
Avg Cost/Share
$2.62
Shares
7,767
Total Value
$20,349.54
Owned After
151,726
SEC Form 4
Chief Executive Officer
Avg Cost/Share
$2.62
Shares
11,594
Total Value
$30,376.28
Owned After
796,296
SEC Form 4
Chief Data Officer
Avg Cost/Share
$2.62
Shares
7,073
Total Value
$18,531.26
Owned After
168,596
SEC Form 4
General Counsel
Avg Cost/Share
$2.62
Shares
7,059
Total Value
$18,494.58
Owned After
119,758
SEC Form 4
Chief Financial Officer
Avg Cost/Share
$2.62
Shares
6,351
Total Value
$16,639.62
Owned After
278,319
SEC Form 4
Chief Information Officer
Avg Cost/Share
$2.62
Shares
6,528
Total Value
$17,103.36
Owned After
89,404
SEC Form 4
Director
Avg Cost/Share
$3.04
Shares
221
Total Value
$671.84
Owned After
58,032
SEC Form 4
Chief Information Officer
Avg Cost/Share
$3.07
Shares
2,000
Total Value
$6,140.00
Owned After
89,404
SEC Form 4
Chief Information Officer
Avg Cost/Share
$3.18
Shares
2,000
Total Value
$6,360.00
Owned After
89,404
SEC Form 4
Director
Avg Cost/Share
$3.16
Shares
227
Total Value
$717.32
Owned After
58,032
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Boniface John J. | SERA | Chief Scientific Officer | Nov 10, 2025 | Sell | $2.62 | 7,767 | $20,349.54 | 151,726 | |
| Lindgardt Zhenya | SERA | Chief Executive Officer | Nov 10, 2025 | Sell | $2.62 | 11,594 | $30,376.28 | 796,296 | |
| Kearney Paul | SERA | Chief Data Officer | Nov 10, 2025 | Sell | $2.62 | 7,073 | $18,531.26 | 168,596 | |
| Jackson Benjamin | SERA | General Counsel | Nov 10, 2025 | Sell | $2.62 | 7,059 | $18,494.58 | 119,758 | |
| Aerts Austin | SERA | Chief Financial Officer | Nov 10, 2025 | Sell | $2.62 | 6,351 | $16,639.62 | 278,319 | |
| Harrison Robert Gardner | SERA | Chief Information Officer | Nov 10, 2025 | Sell | $2.62 | 6,528 | $17,103.36 | 89,404 | |
| Mirza Mansoor Raza | SERA | Director | Nov 5, 2025 | Sell | $3.04 | 221 | $671.84 | 58,032 | |
| Harrison Robert Gardner | SERA | Chief Information Officer | Nov 4, 2025 | Sell | $3.07 | 2,000 | $6,140.00 | 89,404 | |
| Harrison Robert Gardner | SERA | Chief Information Officer | Oct 7, 2025 | Sell | $3.18 | 2,000 | $6,360.00 | 89,404 | |
| Mirza Mansoor Raza | SERA | Director | Oct 6, 2025 | Sell | $3.16 | 227 | $717.32 | 58,032 |
SERA Breaking Stock News: Dive into SERA Ticker-Specific Updates for Smart Investing
AI Sentiment
Highly Positive
8/10
See how SERA stacks up against similar companies in the market
Enhance your trading experience with our free tools
The information presented on this page, "SERA Sera Prognostics Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.